Lipocine logo

Lipocine Share Price Today

(NASDAQ: LPCN)

Lipocine share price is $3.38 & ₹293.96 as on 6 Mar 2025, 2.30 'hrs' IST

$3.38

0.31

(10.1%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lipocine share price in Dollar and Rupees. Guide to invest in Lipocine stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lipocine, along with analyst recommendations, forecasts, and comprehensive financials.

Lipocine share price movements

  • Today's Low: $3.05
    Today's High: $3.62

    Day's Volatility :15.78%

  • 52 Weeks Low: $2.91
    52 Weeks High: $11.79

    52 Weeks Volatility :75.32%

Lipocine (LPCN) Returns

PeriodLipocine IncIndex (Russel 2000)
3 Months
-32.26%
0.0%
6 Months
-9.63%
0.0%
1 Year
-5.59%
0.0%
3 Years
-86.83%
-11.6%

Lipocine (LPCN) Key Statistics

in dollars & INR

Previous Close
$3.07
Open
$3.14
Today's High
$3.6215
Today's Low
$3.05
Market Capitalization
$16.4M
Today's Volume
$28.9K
52 Week High
$11.79
52 Week Low
$2.9101
Revenue TTM
$7.9M
EBITDA
$-5.3M
Earnings Per Share (EPS)
$-0.77
Profit Margin
-51.19%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.5%

How to invest in Lipocine Stock (LPCN) from India?

It is very easy for Indian residents to invest directly in Lipocine from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lipocine stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lipocine or LPCN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lipocine or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lipocine shares which would translate to 0.257 fractional shares of Lipocine as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lipocine, in just a few clicks!

Returns in Lipocine (LPCN) for Indian investors in Rupees

The Lipocine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lipocine investment value today

Current value as on today

₹99,362

Returns

₹638

(-0.64%)

Returns from Lipocine Stock

₹5,587 (-5.59%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Lipocine (LPCN)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lipocine Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lipocine

  • Vanguard Group Inc

    4.14%

  • BlackRock Inc

    1.67%

  • Geode Capital Management, LLC

    1.07%

  • Renaissance Technologies Corp

    0.67%

  • Susquehanna International Group, LLP

    0.47%

  • Dimensional Fund Advisors, Inc.

    0.38%

Analyst Recommendation on Lipocine

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Lipocine(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Lipocine Stock (LPCN)

What analysts predicted

Upside of 195.86%

Target:

$10.00

Current:

$3.38

Insights on Lipocine Stock (Ticker Symbol: LPCN)

  • Price Movement

    In the last 7 days, LPCN stock has moved up by 7.0%
  • LPCN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 72.1%
  • LPCN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 138.3%
  • Price to Sales

    ForLPCN every $1 of sales, investors are willing to pay $2.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Lipocine Technicals Summary

Sell

Neutral

Buy

Lipocine is currently in a neutral trading position according to technical analysis indicators.

Lipocine (LPCN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lipocine Inc logo
-25.55%
-9.63%
-5.59%
-86.83%
-61.27%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lipocine Inc logo
NA
NA
0.0
0.0
-0.19
-0.15
NA
3.58
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lipocine Inc logo
Buy
$16.4M
-61.27%
NA
-51.19%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Lipocine

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include TLANDO XR a candidate for oral TRT for once daily dosing, which has completed Phase 2b clinical study; LPCN 1148, an oral prodrug of bioidentical testosterone, being developed for the treatment of cirrhosis, currently under Phase 2 clinical studies; LPCN 1154, An oral neurosteroid, being developed for the treatment of postpartum depression, currently under Phase 2 studies; LPCN 2101, a NAS candidate, for women with epilepsy; and LPCN 2203 for essential tremor. It is also involved in the development of LPCN 1144, an oral prodrug of bioidentical testosterone for the treatment of pre-cirrhotic non-alcoholic steatohepatitis, which has completed Phase 2 testing; and LPCN 1107, an oral product candidate of 17-alpha-hydroxy progesterone caproate product, currently under Phase 3 studies for the prevention of recurrent preterm birth. The company was founded in 1997 and is headquartered in Salt Lake City, Utah.
Organization
Lipocine
Employees
17
CEO
Dr. Mahesh V. Patel Ph.D.
Industry
Health Technology

Management People of Lipocine

NameTitle
Dr. Mahesh V. Patel Ph.D.
Co-Founder, Interim Principal Financial Officer, Director, President & CEO
Ms. Krista Fogarty
Principal Accounting Officer & Corporate Controller
Dr. Nachiappan Chidambaram Ph.D.
Senior Vice President of Research & Development
Mr. Logan Morse
Vice President of Sales, Marketing & Operations
Dr. Anthony DelConte M. D., M.D.
Chief Medical Director

Important FAQs about investing in LPCN Stock from India :

What is Lipocine share price today?

Lipocine share price today stands at $3.38, Open: $3.14 ; Previous Close: $3.07 ; High: $3.62 ; Low: $3.05 ; 52 Week High: $11.79 ; 52 Week Low: $2.91.

The stock opens at $3.14, after a previous close of $3.07. The stock reached a daily high of $3.62 and a low of $3.05, with a 52-week high of $11.79 and a 52-week low of $2.91.

Can Indians buy Lipocine shares?

Yes, Indians can invest in the Lipocine (LPCN) from India.

With INDmoney, you can buy Lipocine at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lipocine at zero transaction cost.

How can I buy Lipocine shares from India?

It is very easy to buy Lipocine from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lipocine (LPCN) be purchased?

Yes, you can buy fractional shares of Lipocine with INDmoney app.

What are the documents required to start investing in Lipocine stocks?

To start investing in Lipocine, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lipocine Stock (LPCN)?

Today’s highest price of Lipocine (LPCN) is $3.62.

Today’s lowest price of Lipocine (LPCN) is $3.05.

What is today's market capitalisation of Lipocine?

Today's market capitalisation of Lipocine LPCN is 16.4M

What is the 52 Week High and Low Range of Lipocine Stock (LPCN)?

  • 52 Week High

    $11.79

  • 52 Week Low

    $2.91

What are the historical returns of Lipocine (LPCN)?

  • 1 Month Returns

    -25.55%

  • 3 Months Returns

    -9.63%

  • 1 Year Returns

    -5.59%

  • 5 Years Returns

    -61.27%

Who is the Chief Executive Officer (CEO) of Lipocine ?

Dr. Mahesh V. Patel Ph.D. is the current Chief Executive Officer (CEO) of Lipocine.